AstraZeneca’s Datroway gets EU panel backing for breast cancer

🌐 Investing.com (CY) —
AstraZeneca’s Datroway gets EU panel backing for breast cancer

AI Summary

The European Union panel has given backing to AstraZeneca's drug Datroway for the treatment of breast cancer, signaling a positive regulatory step forward for the company. This endorsement is crucial for advancing the drug towards market availability in the EU.

Markets Health AstraZeneca Datroway EU approval breast cancer pharmaceuticals regulatory clinical development

Read original source →